Paradoxically, elevated TIMP1 expression has been consistently linked to unfavorable prognoses across various cancers, including breast, lung, endometrial, pancreatic, and skin cancers, including melanoma and UVM [35,36,37,38,39,40,41]. This evidence concerns the gene TIMP1 and cancer.